NewhouseMT, DolovichMB. Control of asthma by aerosols (review). N Engl J Med1986;315(14):870–874.
2.
JansonC.Plasma levels and effects of salbutamol after inhaled or i.v. administration in stable asthma. Eur Respir J1991;4(5):544–550.
3.
BoucherBA, KuhlDA, CoffeyBC, FabianTC. Drug use in a trauma intensive-care unit. Am J Hosp Pharm1990;47(4):805–810.
4.
DhandR, TobinMJ. Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients (review). Eur Respir J1996;9(3):585–595.
5.
BrainJD, ValbergPA. Deposition of aerosol in the respiratory tract (review). Am Rev Respir Dis1979;120(6):1325–1373.
6.
GrossNJ, JenneJW, HessD.Bronchodilator therapy. In: TobinMJ, ed. Principles and practice of mechanical ventilation. New York: McGraw Hill, 1994:1077–1123.
7.
FinkJB, DhandR.Aerosol therapy. In: FinkJB, HuntG, eds. Clinical practice in respiratory care. Philadelphia: Lippincott Raven, 1998.
8.
YuCP, NicolaidesP, SoongTT. Effect of random airway sizes on aerosol deposition. Am Ind Hyg Assoc J1979;40(11):999–1005.
HessD, HorneyD, SnyderT.Medication-delivery performance of eight small-volume, hand-held nebulizers: effects of diluent volume, gas flowrate, and nebulizer model. Respir Care1989;34(8):717–723.
11.
HessD, FisherD, WilliamsP, PoolerS, KacmarekRM. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest1996;110(2):498–505.
12.
DhandR, MalikSK, BalakrishnanM, VermaSR. High speed pho- tographic analysis of aerosols produced by metered dose inhalers. J Pharm Pharmacol1988;40(6):429–430.
13.
DolovichM, RuffinRE, RobertsR, NewhouseMT. Optimal deliv- ery of aerosols from metered dose inhalers. Chest1981;80(6 Suppl):911–915.
14.
MorenF, AnderssonA.Fraction of dose exhaled after administration of pressurized inhalation aerosols. Int J Pharmaceutics1980;6:295–300.
15.
FullerHD, DolovichMB, PosmituckG, PackWW, NewhouseMT. Pressurized aerosol versus jet aerosol delivery to mechanically ven- tilated patients: comparison of dose to the lungs. Am Rev Respir Dis1990;141(3):440–444.
16.
Aerosol consensus statement. Consensus Conference on Aerosol De- livery. Chest1991;100(4):1106–1109.
17.
FinkJB, DhandR, GrychowskiJ, FaheyPJ, TobinMJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a me- tered-dose inhaler during mechanical ventilation and defining effi- ciency-enhancing factors. Am J Respir Crit Care Med1999;159 (in press).
18.
FullerHD, DolovichMB, ChambersC, NewhouseMT. Aerosol delivery during mechanical ventilation: a predictive in vitro lung model. J Aerosol Med1992;5:251–259.
19.
O'RiordanTG, GrecoMJ, PerryRJ, SmaldoneGC. Nebulizer func- tion during mechanical ventilation. Am Rev Respir Dis1992;145(5):1117–1122.
20.
O'DohertyMJ, ThomasSHL, PageCJ, TreacherDF, NunanTO. Delivery of a nebulized aerosol to a lung model during mechanical ventilation: effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis1992;146(2):383–388.
21.
ThomasSHL, O'DohertyMJ, PageCJ, TreacherDF, NunanTO. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Respir Dis1993;148(4 pt 1):872–877.
22.
RauJL, HarwoodRJ, GroffJL. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an in vitro study. Chest1992;102(3):924–930.
23.
TaylorRH, LermanJ, ChambersC, DolovichM.Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest1993;103(3):920–924.
24.
DiotP, MorraL, SmaldoneGC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and neb- ulizer efficiency. Am J Respir Crit Care Med1995;152(4 pt 1):1391–1394.
25.
FinkJB, DhandR, DuarteAG, JenneJW, TobinMJ. Aerosol delivery from a metered dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med1996;154(2 pt 1):382–387.
26.
HughesJM, SaezJ.Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care1987;32(12):1131–1135.
27.
McPeckM, O'RiordanTG, SmaldoneGC. Choice of mechanical ventilator: influence on nebulizer performance. Respir Care1993;38(8):887–895.
28.
HarveyCJ, O'DohertyMJ, PageCJ, ThomasSHL, NunanTO, and TreacherDF. Effect of a spacer on pulmonary aerosol deposition from a jet nebulizer during mechanical ventilation. Thorax1995;50(1):50–53.
29.
DhandR, TobinMJ. Bronchodilator delivery with metered-dose in- halers in mechanically-ventilated patients (review). Eur Respir J1996;9(3):585–595.
30.
BishopMJ, LarsonRP, BuschmanDL. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology1990;73(6):1263–1265.
31.
FullerHD, DolovichMB, TurpieFH, NewhouseMT. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients: a study comparing four different actuator devices. Chest1994;105(1):214–218.
32.
ManthousCA, HallJB, SchmidtGA, WoodLDH. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated pa- tients. Am Rev Respir Dis1993;148(6 pt 1):1567–1570.
33.
AhrensRC, RiesRA, PopendorfW, WieseJA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol1986;2(1):19–26.
34.
GarnerSS, WiestDB, BradleyJW. Albuterol delivery by metered- dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy1994;14(2):210–214.
35.
SvartengrenM, AndersonM, PhilipsonK, CamnerP.Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res1989;15(4):575–585.
36.
AndersonM, SvartengrenM, BylinG., PhilipsonK, CamnerP.Deposition in asthmatics of particles inhaled in air or in helium- oxygen. Am. J. Respir. Crit. Care Med.1993;147(3):524–528.
37.
FinkJ, DhandR, FaheyP, TobinMJ. Heliox increased delivery of albuterol from a MDI during mechanical ventilation: an in-vitro model (abstract). Am J Respir Crit Care Med1997;155:A268.
38.
FinkJ, DhandR, FaheyP, TobinMJ. Exhaled aerosol accounts for differences between in vitro and in vivo delivery from a metered- dose inhaler during mechanical ventilation (abstract). Am J Respir Crit Care Med1996;153:A377.
39.
O'RiordanTG, PalmerLB, SmaldoneGC. Aerosol deposition in mechanically ventilated patients: optimizing nebulizer delivery. Am J Respir Crit Care Med1994;149(1):214–219.
40.
ThomasSHL, O'DohertyMJ, FidlerHM, PageCJ, TreacherDF, NunanTO. Pulmonary deposition of a nebulized aerosol during me- chanical ventilation. Thorax1993;48(2):154–159.
41.
MacIntyreNR, SilverRM, MillerCW, SchulerF, ColemanRE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med1985;13(2):81–84.
42.
TanYK, SoldinSJ. Determination of salbutamol in human serum by reversed-phase high-performance liquid chromatography with am- perometric detection. J Chromatogr1984;311(2):311–317.
43.
GuptaRN, FullerHD, DolovichMB. Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration. J Chromatogr B Biomed Appl1994;654(2):205–211.
44.
DuarteAG, DhandR, ReidR, FinkJB, FaheyPJ, TobinMJ, JenneJW. Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration. Am J Respir Crit Care Med1996;154(6 pt 1):1658–1663.
45.
CravenDE, LichtenbergDA, GoularteTA, MakeBJ, McCabeWR. Contaminated medication nebulizers in mechanical ventilator cir- cuits: source of bacterial aerosols. Am J Med1984;77(5):834–838.
46.
HamillRJ, HoustonED, GeorghiouPR, WrightCE, KozaMA, CadleRM, et al. An outbreak of Burkholderia (formerly Pseudomo- nas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med1995;122(10):762–766.
47.
WegenerT, WretmanS, SandhagenB, NystromSO. Effect of ipra- tropium bromide aerosol on respiratory function in patients under ventilator treatment. Acta Anaesthesiol Scand1987;31(7):652–654.
48.
BernasconiM, BrandoleseR, PoggiR, ManzinE, RossiA.Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med1990;16(2):108–114.
49.
FernandezA, LazaroA, GarciaA, AragonC, CerdaE.Bronchodi- lators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am Rev Respir Dis1990;141(1):164–168.
50.
YangSC, YangSP, LeeTS. Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis. Chest1994;105(5):1511–1515.
51.
FernandezA, MunozJ, de la CalleB, AliaI, EzpeletaA, de la CalMA, ReyesA.Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med1994;20(3):199–202.
52.
ManthousCA, ChatilaW, SchmidtGA, HallJB. Treatment of bron- chospasm by metered-dose inhaler albuterol in mechanically venti- lated patients. Chest1995;107(1):210–213.
53.
DhandR, JubranA, TobinMJ. Bronchodilator delivery by metered- dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med1995;151(6):1827–1833.
54.
DhandR, DuarteAG, JubranA, JenneJW, FinkJB, FaheyPJ, TobinMJ. Dose-response to bronchodilator delivered by metered-dose in- haler in ventilator-supported patients. Am J Respir Crit Care Med1996;154(2 pt 1):388–393.
55.
ReinosoMA, GraceyDR, HubmayrRD. Interrupter mechanics of patients admitted to a chronic ventilator dependency unit. Am Rev Respir Dis1993;148(1):127–131.
56.
FresoliRPJr, SmithRM, YoungJA, GottshallSC. Use of aerosol isoproterenol in an anesthesia circuit. Anesth Analg1968;47(2):127–132.
57.
GoldMI. Treatment of bronchospasm during anesthesia. Anesth Analg1975;54(6):783–786.
58.
SpragueDH. Treatment of intraoperative bronchospasm with nebu- lized isoetharine. Anesthesiology1977;46(3):222–224.
59.
GayPC, RodarteJR, TayyabM, HubmayrRD. Evaluation of bron- chodilator responsiveness in mechanically ventilated patients. Am Rev Respir Dis1987;136(4):880–885.
60.
GayPC, PatelHG, NelsonSB, GillesB, HubmayrRD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ven- tilated patients. Chest1991;99(1):66–71.
BatesJHT, RossiA, Milic-EmiliJ.Analysis of the behavior of the respiratory system with constant inspiratory flow. J Appl Physiol1985;58(6):1840–1848.
63.
JacksonAC, MilhornHTJr, NormanJR.A reevaluation of the interrupter technique for airway resistance measurement. J Appl Physiol1974;36(2):264–268.
64.
PepePE, MariniJJ. Occult positive end-expiratory pressure in me- chanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis1982;126(1):166–170.
65.
DolleryCT, WilliamsFM, DraffanGH, WiseG, SahyounH, Pater- sonGW, WalkerSR. Arterial blood levels of fluorocarbons in asth- matic patients following use of pressurized aerosols. Clin Pharmacol Ther1974;15(1):59–66.
66.
SilvergladeA.Cardiac toxicity of aerosol propellants. JAMA1972;222(7):827–828.
67.
Spahr-SchopferIA, LermanJ, CutzE, NewhouseMT, DolovichM.Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Crit Care Med1994;150(3):790–794.
68.
TurnerJR, CorkeryKJ, EckmanD, GelbAM, LipavskyA, SheppardD.Equivalence of continuous flow nebulizer and metered-dose in- haler with reservoir bag for treatment of acute airflow obstruction. Chest1988;93(3):476–481.
69.
AlvineGF, RodgersP, FitzsimmonsKM, AhrensRC. Disposable jet nebulizers: how reliable are they?Chest1992;101(2):316–319.
SummerW, ElstonR, TharpeL, NelsonS, HaponikEF. Aerosol bronchodilator delivery methods. Relative impact on pulmonary func- tion and cost of respiratory care. Arch Intern Med1989;149(3):618–623.
72.
BowtonDL, GoldsmithWM, HaponikEF. Substitution of metered- dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest1992;101(2):305–308.